Αποτελέσματα Αναζήτησης
UAntwerp researchers have developed a new immune cell therapy that can destroy these connective tissue cells as well as the underlying cancer cells, improving treatment outcomes. There is a great need to improve treatment outcomes for pancreatic cancer and advanced colorectal cancer.
We have a strong national and international track record on the development of cellular immunotherapies and gene engineering in the context of cancer and autoimmune diseases as well as stem cell research.
The Antwerp University Hospital (UZA) has a leading role in the exploration of new approaches for cell therapy. At the end of 2005 the Center for Cell Therapy and Regenerative Medicine was founded, a multidisciplinary platform in which innovative therapies are being investigated.
20 Μαΐ 2020 · In this Review, we emphasize the role of T cells in modern cancer immunotherapies and discuss three different categories of immunotherapeutic approaches to treat cancer: immune checkpoint...
5 ημέρες πριν · Immune cell therapy based on chimeric antigen receptor (CAR) technology platform has been greatly developed. The types of CAR immune cell therapy have expanded from T cells to innate immune cells such as NK cells and macrophages, and the diseases treated have expanded from hematological malignancies to non-tumor fields such as infectious diseases and autoimmune diseases. Among them, CAR-T and ...
1 Ιουλ 2020 · Immunotherapy, aiming to boost natural defenses to eliminate malignant cells, is a monumental breakthrough for cancer treatment and has revolutionized the field of oncology.
19 Απρ 2022 · Lessons learned from cancer immunotherapies have set the stage for application of engineered cellular therapy to autoimmune diseases, genetic disorders, infectious diseases and regenerative...
